BPC-157 (Pentadecapeptide)

BPC-157 Storage, Stability and Reconstitution

UKPWritten & reviewed by William Heath · Editor, UK Peptides research library2 min readLast reviewed 2026-08-233 cited sources

The short answer

BPC-157 is supplied lyophilised and is most stable dry, cold and dark. Its proline content confers enzymatic resistance and it lacks cysteine and methionine, so the common chemical degradation routes do not apply, leaving hydrolysis and physical handling as the practical concerns.

Key facts

Supplied as
White lyophilised powder
Enzymatic resistance
High (four prolines)
Disulfide risk
None (no cysteine)
Oxidation risk
Low (no methionine)
Main chemical route
Hydrolysis
Physical concern
Adsorption; freeze-thaw damage

Why the stability claim does not change storage

This is the point most likely to be got wrong. BPC-157 is described as stable in gastric juice, which is a claim about enzymatic and acidic resistance. Storage guidance addresses chemical hydrolysis, which proceeds without any enzyme and is a function of water, temperature and time. Proline protects against the first and does nothing about the second.

What the composition rules out

No cysteine, so no disulfide formation or scrambling and no reducing agent required. No methionine, so no thioether oxidation and no +16 Da satellite on a mass spectrum. Between them these account for most of what goes wrong with research peptides, and neither applies here.

Research material referenced

BPC-157 5mg, third-party HPLC tested

Buy BPC-157 · £16.95

What remains

Backbone hydrolysis, slowed but not prevented by proline. And an aspartate-glycine sequence at positions 11 to 13, which in some peptides is a site for aspartate-related rearrangement. This is useful to know, though it is a slower process than the routes that dominate elsewhere.

Reconstitution

Introduce diluent gently down the vial wall rather than onto the powder, and swirl rather than shake. Foaming indicates an air-liquid interface has formed, which is where peptides unfold before aggregating. BPC-157 is hydrophilic and dissolves readily, so vigorous agitation is never needed.

After reconstitution

Aliquot into single-use volumes. Each freeze-thaw cycle concentrates solutes at the advancing ice boundary and creates fresh interfaces, and neither is prevented by the peptide's enzymatic robustness. Chemical and physical stability are separate properties, and BPC-157 is strong on the first and ordinary on the second.

Signs of a problem

Cloudiness, particulates or discolouration in a reconstituted solution mean the material should not be relied on for a measurement. Difficulty dissolving at a concentration that previously worked suggests aggregation, which for a peptide this soluble would be a meaningful signal.

Frequently asked questions

If BPC-157 is stable, why store it cold?

The stability claim concerns enzymatic and acidic degradation. Chemical hydrolysis needs no enzyme and is what cold, dry storage addresses.

Does it need a reducing agent?

No. There is no cysteine in the sequence.

Why avoid shaking?

Shaking creates an air-liquid interface where peptides unfold and aggregate. Foam is the visible evidence.

Continue researching

Peer-reviewed guides, comparators and matched reference materials.

Primary sources & clinical trials

Peer-reviewed research and registered trials from PubMed, ClinicalTrials.gov, PubChem, FDA and NIH. All links open in a new tab and point to the primary source, so every claim can be verified at origin.

Browse the wider literature

Live database searches, not fixed citations. Results change as new work is indexed.

UKP

Written and reviewed by

William Heath · Editor, UK Peptides research library

William Heath edits the UK Peptides research library. He is responsible for what is published here: every article is sourced to primary literature, every purity or identity statement traces to a signed third-party certificate for a specific lot, and corrections are made in place with the review date updated. No scientific or medical credentials are claimed on this site; the evidence is carried by the cited sources and the certificates, not by the byline.

More BPC-157 (Pentadecapeptide) articles

Research use only. The information above is provided for scientific and educational reference. Compounds referenced are not approved for human use and are supplied for in vitro research or reference-material purposes only. No efficacy, safety, or therapeutic claims are made.